MENU
XNCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xencor (XNCR) Earnings Date & Reports

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

XNCR is expected to report earnings to rise 813.63% to -73 cents per share on March 04

Xencor XNCR Stock Earnings Reports
Q4'25
Est.
$-0.73
Q3'25
Beat
by $0.61
Q2'25
Beat
by $0.31
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.19
The last earnings report on November 05 showed earnings per share of -7 cents, beating the estimate of -68 cents. With 260.48K shares outstanding, the current market capitalization sits at 1.03B.
View a ticker or compare two or three
XNCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. XNCR showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutics to treat autoimmune and allergic diseases, cancer and other conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
465 North Halstead Street
Phone
+1 626 305-5900
Employees
256
Web
https://www.xencor.com